AEON Biopharma Inc. (AEON)
AEON Biopharma Statistics
Share Statistics
AEON Biopharma has 1.11M shares outstanding. The number of shares has increased by 7.57% in one year.
Shares Outstanding | 1.11M |
Shares Change (YoY) | 7.57% |
Shares Change (QoQ) | 1.13% |
Owned by Institutions (%) | n/a |
Shares Floating | 364.54K |
Failed to Deliver (FTD) Shares | 7.88K |
FTD / Avg. Volume | 0.24% |
Short Selling Information
The latest short interest is 164.26K, so 0.21% of the outstanding shares have been sold short.
Short Interest | 164.26K |
Short % of Shares Out | 0.21% |
Short % of Float | 0.94% |
Short Ratio (days to cover) | 1.6 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -0.18. AEON Biopharma's PEG ratio is 0.
PE Ratio | 0 |
Forward PE | -0.18 |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | 0 |
P/FCF Ratio | 0 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for AEON Biopharma Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.48, with a Debt / Equity ratio of 0.
Current Ratio | 0.48 |
Quick Ratio | 0.48 |
Debt / Equity | 0 |
Total Debt / Capitalization | -0.18 |
Cash Flow / Debt | null |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is null% and return on capital (ROIC) is 31.6%.
Return on Equity (ROE) | null% |
Return on Assets (ROA) | null% |
Return on Capital (ROIC) | 31.6% |
Revenue Per Employee | $0 |
Profits Per Employee | $-5,255,600 |
Employee Count | 10 |
Asset Turnover | null |
Inventory Turnover | n/a |
Taxes
Income Tax | -160.49K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -99.94% in the last 52 weeks. The beta is 0.26, so AEON Biopharma's price volatility has been higher than the market average.
Beta | 0.26 |
52-Week Price Change | -99.94% |
50-Day Moving Average | 8.36 |
200-Day Moving Average | 59.79 |
Relative Strength Index (RSI) | 24.3 |
Average Volume (20 Days) | 3.32M |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -48.43M |
Net Income | -52.56M |
EBITDA | -48.36M |
EBIT | n/a |
Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 5.16M in cash and 278K in debt, giving a net cash position of 4.88M.
Cash & Cash Equivalents | 5.16M |
Total Debt | 278K |
Net Cash | 4.88M |
Retained Earnings | -473.6M |
Total Assets | 4M |
Working Capital | -8.36M |
Cash Flow
In the last 12 months, operating cash flow was -35.58M and capital expenditures -306K, giving a free cash flow of -35.89M.
Operating Cash Flow | -35.58M |
Capital Expenditures | -306K |
Free Cash Flow | -35.89M |
FCF Per Share | 0 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AEON does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 0% |
FCF Yield | -4487.91% |
Analyst Forecast
The average price target for AEON is $360, which is 49900% higher than the current price. The consensus rating is "Buy".
Price Target | $360 |
Price Target Difference | 49900% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Stock Splits
The last stock split was on Feb 26, 2025. It was a backward split with a ratio of 1:72.
Last Split Date | Feb 26, 2025 |
Split Type | backward |
Split Ratio | 1:72 |
Scores
Altman Z-Score | -183.91 |
Piotroski F-Score | 5 |